Survey of Machine Learning Techniques in Drug Discovery.

Drug discovery artificial intelligence deep learning drug development machine learning pharmacology.

Journal

Current drug metabolism
ISSN: 1875-5453
Titre abrégé: Curr Drug Metab
Pays: Netherlands
ID NLM: 100960533

Informations de publication

Date de publication:
2019
Historique:
received: 06 09 2017
revised: 01 01 2018
accepted: 19 03 2018
pubmed: 21 8 2018
medline: 28 11 2019
entrez: 21 8 2018
Statut: ppublish

Résumé

Drug discovery, which is the process of discovering new candidate medications, is very important for pharmaceutical industries. At its current stage, discovering new drugs is still a very expensive and time-consuming process, requiring Phases I, II and III for clinical trials. Recently, machine learning techniques in Artificial Intelligence (AI), especially the deep learning techniques which allow a computational model to generate multiple layers, have been widely applied and achieved state-of-the-art performance in different fields, such as speech recognition, image classification, bioinformatics, etc. One very important application of these AI techniques is in the field of drug discovery. We did a large-scale literature search on existing scientific websites (e.g, ScienceDirect, Arxiv) and startup companies to understand current status of machine learning techniques in drug discovery. Our experiments demonstrated that there are different patterns in machine learning fields and drug discovery fields. For example, keywords like prediction, brain, discovery, and treatment are usually in drug discovery fields. Also, the total number of papers published in drug discovery fields with machine learning techniques is increasing every year. The main focus of this survey is to understand the current status of machine learning techniques in the drug discovery field within both academic and industrial settings, and discuss its potential future applications. Several interesting patterns for machine learning techniques in drug discovery fields are discussed in this survey.

Sections du résumé

BACKGROUND BACKGROUND
Drug discovery, which is the process of discovering new candidate medications, is very important for pharmaceutical industries. At its current stage, discovering new drugs is still a very expensive and time-consuming process, requiring Phases I, II and III for clinical trials. Recently, machine learning techniques in Artificial Intelligence (AI), especially the deep learning techniques which allow a computational model to generate multiple layers, have been widely applied and achieved state-of-the-art performance in different fields, such as speech recognition, image classification, bioinformatics, etc. One very important application of these AI techniques is in the field of drug discovery.
METHODS METHODS
We did a large-scale literature search on existing scientific websites (e.g, ScienceDirect, Arxiv) and startup companies to understand current status of machine learning techniques in drug discovery.
RESULTS RESULTS
Our experiments demonstrated that there are different patterns in machine learning fields and drug discovery fields. For example, keywords like prediction, brain, discovery, and treatment are usually in drug discovery fields. Also, the total number of papers published in drug discovery fields with machine learning techniques is increasing every year.
CONCLUSION CONCLUSIONS
The main focus of this survey is to understand the current status of machine learning techniques in the drug discovery field within both academic and industrial settings, and discuss its potential future applications. Several interesting patterns for machine learning techniques in drug discovery fields are discussed in this survey.

Identifiants

pubmed: 30124147
pii: CDM-EPUB-92486
doi: 10.2174/1389200219666180820112457
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

185-193

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Natalie Stephenson (N)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

Emily Shane (E)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

Jessica Chase (J)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

Jason Rowland (J)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

David Ries (D)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

Nicola Justice (N)

Department of Mathematics, Pacific Lutheran University, Tacoma, WA 98447, United States.

Jie Zhang (J)

Key Laboratory of Hebei Province for Plant Physiology and Molecular Pathology, College of Life Sciences, Hebei Agricultural University, Baoding, China.

Leong Chan (L)

School of Business, Pacific Lutheran University, Tacoma, WA 98447, United States.

Renzhi Cao (R)

Department of Computer Science, Pacific Lutheran University, Tacoma, WA 98447, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH